P00797 RENI_HUMAN
Gene name: REN
Protein name: Renin
List of molecules and drugs that target protein P00797
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | P00797_DB00212 | DB00212 | Remikiren | inhibitor | UXIGZRQVLGFTOU-VQXQMPIVSA-N | CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1 | |
2 | P00797_DB00350 | DB00350 | Minoxidil | n/a | ZFMITUMMTDLWHR-UHFFFAOYSA-N | NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1 | |
3 | P00797_DB00722 | DB00722 | Lisinopril | inhibitor | RLAWWYSOJDYHDC-BZSNNMDCSA-N | NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O | |
4 | P00797_DB01844 | DB01844 | N,N-dimethylformamide | n/a | ZMXDDKWLCZADIW-UHFFFAOYSA-N | CN(C)C=O | |
5 | P00797_DB02296 | DB02296 | Isoamyl alcohol | n/a | PHTQWCKDNZKARW-UHFFFAOYSA-N | CC(C)CCO | |
6 | P00797_DB02803 | DB02803 | 3-Phenyl-1,2-Propandiol | n/a | JHWQMXKQJVAWKI-VIFPVBQESA-N | OC[C@@H](O)CC1=CC=CC=C1 | |
7 | P00797_DB03024 | DB03024 | 2-Methyl-3-(2-Aminothiazolo)Propanal | n/a | KFMAJVLZSDMFBV-YFKPBYRVSA-N | [H][C@](C)(CC1=CSC(N)=N1)C=O | |
8 | P00797_DB03395 | DB03395 | Enalkiren | inhibitor | IC50(nM) = 0.75 | KQXVERRYBYGQJZ-WRPDIKACSA-N | COC1=CC=C(C[C@H](NC(=O)CC(C)(C)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC2CCCCC2)[C@@H](O)[C@@H](O)CC(C)C)C=C1 |
9 | P00797_DB03736 | DB03736 | 2-Cyclopropylmethylenepropanal | n/a | NOQCSSAEKDLHCI-LURJTMIESA-N | [H][C@](C)(CC1CC1)C=O | |
10 | P00797_DB03968 | DB03968 | 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine | n/a | YARDEGUIPATLSG-UHFFFAOYSA-N | CN1C(=O)CCC1(C)C | |
11 | P00797_DB04379 | DB04379 | N-Methyl-N-(Methylbenzyl)Formamide | n/a | YYPINKULTUCCJA-VIFPVBQESA-N | [H][C@@](C)(N(C)C=O)C1=CC=CC=C1 | |
12 | P00797_DB04387 | DB04387 | 1-Hydroxy-2-Amino-3-Cyclohexylpropane | n/a | QWDRYURVUDZKSG-VIFPVBQESA-N | N[C@H](CO)CC1CCCCC1 | |
13 | P00797_DB06899 | DB06899 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | n/a | RMEVNJZCKDVVND-UHFFFAOYSA-N | CCC1=NC(N)=NC(N)=C1C1=CC=C2SC(C)(C)C(=O)N(CCNC(C)=O)C2=C1 | |
14 | P00797_DB06967 | DB06967 | 6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE | n/a | IC50(nM) = 173.0 | MLSVRCGEBXIIQO-UHFFFAOYSA-N | CCC1=NC(N)=NC(N)=C1C1=CC2=C(C=C1)C1=CC=CC=C1N2CCCOC |
15 | P00797_DB07059 | DB07059 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE | n/a | IC50(nM) = 20.0 | GBXSOZDYCSBLQX-UHFFFAOYSA-N | CCC1=NC(N)=NC(N)=C1C1=CC2=C(OC(C)(C)C(=O)N2CCNC(C)=O)C=C1 |
16 | P00797_DB07113 | DB07113 | (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE | n/a | KHZQOXQOUCGGGA-NRFANRHFSA-N | [H][C@]1(OC2=C(C=C(C=C2)C2=C(N)N=C(N)N=C2CC)N(CCCOC)C1=O)C1=CC(F)=CC(F)=C1 | |
17 | P00797_DB07174 | DB07174 | 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE | n/a | IC50(nM) = 90.0 | WPAPODFGOZXFLG-UHFFFAOYSA-N | CCC1=C(C(N)=NC(N)=N1)C1=CC=C2OC(C)(C)C(=O)N(CCCOC)C2=C1 |
18 | P00797_DB07244 | DB07244 | 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE | n/a | IC50(nM) = 4000.0 | SRRWXMSVQYQCRX-UHFFFAOYSA-N | CCC1=C(C(N)=NC(N)=N1)C1=CC=C(NCC2=CC(F)=CC(F)=C2)C=C1 |
19 | P00797_DB08099 | DB08099 | 6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine | n/a | UOYVKYJWAXJTTE-NRFANRHFSA-N | [H][C@]1(CCC2=CC=C(C=C2N1CCCOC)C1=C(N)N=C(N)N=C1CC)C1=CC=CC=C1 | |
20 | P00797_DB09026 | DB09026 | Aliskiren | inhibitor | IC50(nM) = 0.4 | UXOWGYHJODZGMF-QORCZRPOSA-N | COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1 |